Conflicting Evidence Of MRNA Technology Raises Serious Concerns About Rush For Use In New Vaccine Development

 The U.S. government and pharmaceutical companies are investing a substantial amount to develop new mRNA vaccines for infectious diseases and cancer, fueling a lucrative mRNA platform valued at $136.2 billion.

Although mRNA platforms are appealing because they reduce costs and shorten the vaccine development timeline, evidence and experience suggest the mRNA technology used for novel COVID-19 vaccines is associated with various harms and neither prevents COVID-19 nor its transmission.

In their recently published paper published in Biomedicines titled, "'Spikeopathy': COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA," the researchers explored peer-reviewed data countering the "Safe and effective" narrative attached to new technologies used to develop mRNA and adenovectorDNA vaccines at "Warp speed" to end the pandemic.

Now that vaccines utilizing mRNA technology have been available and widely distributed for several years, data show these vaccines produce foreign antigens in human tissues and increase the risk of autoimmune, neurological, cardiovascular, inflammatory disorders, and cancers, especially when the vaccine ingredients do not remain localized at the injection site.

In addition to their potential toxicity, LNPs in COVID-19 vaccines have been found to "Induce significant inflammatory cytokine secretion and macrophage inflammatory proteins with cell death." Research has shown this pro-inflammatory effect can increase vaccine adjuvant immunogenicity of COVID-19 mRNA vaccines and contribute to adverse events.

In the presence of polyethylene glycol, a common vaccine ingredient, mRNA in lipid nanoparticles becomes more resistant to degradation and evades the immune system with the nanoparticles helping with biodistribution and bioaccumulation.

Although it's claimed COVID-19 vaccines have saved millions of lives, this belief is founded upon an early 2020 infection fatality rate in China, modeling estimates produced by vaccine manufacturers, and a false assumption vaccines would protect against infection and transmission. 

https://www.theepochtimes.com/health/conflicting-evidence-of-mrna-technology-raises-serious-concerns-about-rush-for-use-in-new-vaccine-development-5480328?utm_source=partner&utm_campaign=ZeroHedge&src_src=partner&src_cmp=ZeroHedge